Celsis has introduced the Celsis Accel system, a robust and easy-to-use rapid microbial screening system for small and medium-size manufacturing companies.
Utilising Celsis’ proprietary reagent technology, the Celsis Accel system reduces time necessary for quality control assessment of microbial contamination. This shortens production cycle times by lowering quarantined inventory levels awaiting quality control release and reduces working capital requirements. Faster quality control results also provide an earlier indication of contamination allowing a faster and more effective investigation and corrective action, thereby reducing the economic impact of the event.
Using its Financial Impact Assessment (FIA), Celsis works with hundreds of manufacturing facilities around the world to evaluate the cost savings of implementing a Celsis system.
The Celsis Accel takes the robustness and ease-of-use of the widely-adopted Celsis Advance platform packaged into a compact system specifically designed for small and medium-size manufacturing facilities. Straightforward software makes the Celsis Accel ideal for home, beauty and pharmaceutical product manufacturers’ busy microbiology labs.
